Treatment of cerebral ischemia with vasoactive drugs.
D000433:1-Propanol / Q000627:therapeutic use; D002245:Carbon Dioxide / Q000627:therapeutic use; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003510:Cyclohexanes / Q000627:therapeutic use; D005029:Ethylenediamines / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008333:Mandelic Acids / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003510:Cyclohexanes; D005029:Ethylenediamines; D008333:Mandelic Acids; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D000433:1-Propanol; D010208:Papaverine